Pericarditis, usually viral in origin, is an infrequent cause of chest pain. Pericarditis due to drug allergy is even less frequent and is thus rarely considered in the diVerential diagnosis. A case is reported of a woman who presented with severe chest pain, caused by minocycline induced pericarditis. Such allergy may be more common than reported. It is suggested that drug induced pericarditis should be included in the diVerential diagnosis of acute chest pain. (Postgrad Med J 2000;76:420-422) Keywords: chest pain; pericarditis; minocycline; drug allergy Chest pain is a frequent cause of acute hospital admission. Demographic factors, duration, exercise relation and site of the pain, associated symptoms, and the electrocardiogram (ECG) are all helpful in establishing the diagnosis. However it is often forgotten that adverse drug reactions can cause chest pain and a full drug history is vital. Here we present a case of pericardial pain due to an adverse reaction to an antibiotic taken for acne.
Chest pain is a frequent cause of acute hospital admission. Demographic factors, duration, exercise relation and site of the pain, associated symptoms, and the electrocardiogram (ECG) are all helpful in establishing the diagnosis. However it is often forgotten that adverse drug reactions can cause chest pain and a full drug history is vital. Here we present a case of pericardial pain due to an adverse reaction to an antibiotic taken for acne.
Case report
A 42 year old woman with longstanding acne was started on minocycline three weeks before presentation. After two weeks' treatment she developed low grade fever, cough, and dyspnoea. She was admitted to another hospital where no clear diagnosis was made. A chest x ray film at this time was normal. After two days' observation, during which she remained afebrile, she was discharged home. Shortly thereafter she developed moderately severe anterior chest pain, related both to deep inspiration and to position, and her general practitioner arranged emergency admission. On examination she was in moderate discomfort, with no abnormal cardiovascular signs. No pericardial or pleural rub was heard. A chest x ray film and an isotope ventilationperfusion scan were normal. Her ECG was very abnormal (fig 1) , and the pattern of the abnormality was not typical for pericardial disease and raised the possibility that she might have a coronary or myocardial problem. Cardiac ultrasound showed vigorous left and right ventricular function, with normal myocardial density, and no evidence of pericardial disease. Cardiac enzymes (including creatine kinase) were not raised. A blood count showed marked eosinophilia, with an absolute eosinophil count of 13 000 × 10 9 /l. Though it was considered likely that minocycline had induced the eosinophilia which in turn had led to pericardial inflammation, the ECG was so worrying that it was felt appropriate to undertake coronary angiography. This revealed normal coronaries. Computed tomography of the thorax showed no evidence of pneumonitis. Once minocycline was discontinued her eosinophil count fell rapidly, her chest pain resolved, and at follow up six weeks later her ECG had returned to normal. The final diagnosis was minocycline induced eosinophilic pericarditis.
Discussion
This patient presented with pleuritic chest pain and a dramatically abnormal ECG, which resolved on discontinuing minocycline. The chest pain was consistent with pericarditis, the ECG was typical for stage III of acute pericarditis (as classified by Braunwald) , and the rapid return of the ECG back to normal as symptoms resolved likewise was consistent with pericarditis. 1 However this pattern of ECG abnormality can be associated with a myocardial or coronary problem and thus further investigations were carried out to exclude these other diagnosis. Active myocarditis was excluded by the absence of diagnostic features (such as a resting sinus tachycardia, heart failure, biochemical evidence of myocardial necrosis, or any ultrasound evidence of cardiac damage) and old myocarditis was excluded by the rapid return of the ECG to normal. The normal cardiac ultrasound examination excluded hypertrophic cardiomyopathy or other heart muscle disorder. Coronary disease was excluded by the normal coronary angiogram. We therefore concluded that her chest pains related to pericarditis, which, given the high eosinophil count could relate to an adverse drug reaction. This view was strengthened by the simultaneous improvement in her symptoms, in her ECG changes, and in the eosinophil count once minocycline was discontinued. It was felt unethical to rechallenge her with minocycline.
Thus this patient developed eosinophilia and pericardial pain as an adverse reaction to minocycline taken for acne. While it is well known that prolonged severe eosinophilia can lead to endomyocardial disease, particularly fibrosis of the ventricular apex or of the atrioventricular valvar apparatus, what is less well recognised is that acute hypereosinophilia can also damage the heart and lead to myocardial disease, including conducting tissue damage or, as in this patient, pericardial disease. [2] [3] [4] [5] Eosinophil mediated pericardial diseases includes pericarditis, pericardial eVusion which can be so large as to result in frank tamponade and, in the chronic phase, pericardial constriction. [6] [7] [8] When eosinophilia is diagnosed it is always important to determine whether there is any underlying cause, such as a vasculitis (particularly ChurgStrauss syndrome or polyarteritis nodusum), asthma atopy, haematological malignancy, and, particularly in tropical countries, parasitosis. [9] [10] [11] In addition to these causes of eosinophilia adverse drug reactions should also be considered. 4 Diagnosis of an adverse drug reaction depends partly on documenting symptomatic improvement on drug withdrawal, and, when felt to be ethically and medically appropriate, demonstrating relapse on rechallenge. 12 "In vitro" lymphocyte simulation tests have been proposed as a safe means of determining the presence of drug sensitivity but their accuracy remains to be established. 13 14 Many drugs have been reported as having the potential to induce pericarditis as an eosinophil mediated serositic adverse reaction and these include allergen immunotherapy, cephalosporin antibiotics, cromolyn sodium, and dantrolene. 7 15-18 Furthermore many drugs have the potential to induce serositis, including pericarditis, in the absence of eosinophilia, sometimes through immune mechanisms, such as drug induced systemic lupus erythematosus or other vasculitis, sometimes because they are cytotoxic (for example azathioprine) and sometimes through unknown mechanisms, such as in the case of 5-aminosalicylic acid or the bisphosphonates. [19] [20] [21] [22] [23] [24] Vaccines such as BCG and peptide drugs such as granulocyte macrophage colony stimulating factor can also rarely cause pericarditis. 25 26 Minocycline has been associated with a number of adverse reactions such as eosinophilic pneumonia and hepatitis, which may be life threatening, dermatitis, lymphadenopathy, neutropenia, and pseudotumour cerebri. 18 27-31 There have to date, however, been no reports of minocycline toxicity resulting primarily in pericardial disease. Minocycline toxicity usually improves completely on drug withdrawal without other treatment being required. However corticosteroids may accelrate recovery from severe minocycline induced lung damage. 14 32 The mechanism of eosinophil mediated cardiac damage is not clear but is likely to be multifactorial. Eosinophils, through the release of proteins contained within their granules, particularly eosinophilic cationic protein and to a lesser extent major basic protein, can induce the release of histamine and tryptase from mast cells isolated from human hearts and thus induce cardiac damage. 33 Furthermore low concentrations of these granular proteins results in damage both to plasma membranes, possibly increasing permeability, and to at least two enzyme complexes (pyruvate dehydrogenase and 2-oxoglutarate dehydrogenase). 34 35 Either directly or indirectly eosinophils may also stimulate the production of inflammatory mediator cytokines, such as interleukin-5. 33 36 37 "In vitro" studies using eosinophils from patients with hypereosinophilic syndromes have shown that the supernatant obtained after overnight culture impairs myocardial contractile function, though this requires intact endothelium. 38 There are also isolated reports that cardiac damage results from eosinophil induced vasospasm.
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Conclusion
We have presented a patient who developed eosinophilia and pericardial pain as an adverse reaction to minocycline taken for acne. Adverse drug reaction should always be considered in the diVerential diagnosis of pericardial pain.
Learning points x Pericarditis may be caused by drug reactions. x ECG changes in drug induced pericarditis may be atypical and can mimic those found in coronary disease. Case report A 44 year old women presented as an emergency with a two day history of generalised abdominal pain and vomiting. She had a history of renal calculi which had been removed some years previously. Subsequent radiology at the time showed delayed renal excretion of contrast by the right kidney, although serum urea and electrolytes were normal. She took no regular prescribed medication. Direct questioning revealed that she suVered from dyspepsia. Examination showed an overweight women who was drowsy, clinically dehydrated, and tachycardic with a heart rate of 110 beats/min. She was apyrexial. Blood pressure was 160/110 mm Hg. On abdominal examination there was generalised tenderness but without signs of peritonism. Serum electrolytes, other biochemistry, and haematological values on admission are shown in table 1. Of note is the corrected serum calcium at 4.0 mmol/l.
A diagnosis of acute pancreatitis was made and she was admitted to the intensive care unit where she required low calcium total parenteral nutrition. A normal liver and gall bladder were seen on abdominal ultrasound. Both kidneys showed a degree of hydronephrosis. The serum calcium normalised within three days.
Intravenous urography performed two days after transfer to a general ward showed no ureteric stones. An ultrasound of the thyroid and parathyroid glands showed a multinodular goitre but no parathyroid masses. Intact parathyroid hormone measured while she was still hypercalcaemic was 8 ng/l (normal range 9-54) suggesting a non-parathyroid cause of the hypercalcaemia. Serum angiotensin converting enzyme was within normal limits at 36 IU/l (15-70) making sarcoidosis unlikely.
Further questioning revealed that the patient had been taking large amounts of "over the counter" calcium containing antacids. For the past two to three years she had been taking up to 70 "Rennies" tablets (Roche Consumer Health, Welwyn Garden City) per week. Each tablet contains 680 mg of calcium carbonate, averaging about 4.5 g of calcium carbonate per day. Barium swallow showed reflux disease with no ulceration.
She was discharged on lansoprazole 20 mg daily and on follow up was asymptomatic with normal electrolytes and a serum calcium within normal limits.
Discussion
Milk alkali syndrome was first described by Sippy in 1915 as the triad of hypercalcaemia, alkalosis, and renal impairment. 1 There have been many cases of pancreatitis secondary to hypercalcaemia, but we have only found one other case in the literature when pancreatitis has been due to milk alkali syndrome. 2 This case fulfils all the criteria for the milk alkali syndrome and in the absence of any other identifiable causes, the pancreatitis can be attributed to it. In the only other reported case of pancreatitis secondary to milk alkali syndrome, the patient had also been self medicating with up to 3 g of calcium daily in an attempt to treat dyspepsia.
Certain metabolic factors can increase susceptibility to the milk alkali syndrome. Our patient may have been at an increased risk of the milk alkali syndrome because of her prior renal pathology resulting in tubular dysfunction, thus making her more susceptible to alkalosis and hypercalcaemia. 3 In the post H 2 -blocker era this syndrome had been becoming increasingly rare. However, over the counter medicines are generally thought to be safe by the public and in the wake of the fear of osteoporosis an increase in consumption of calcium carbonate containing dietary supplements may perhaps reverse this trend. In fact, Beall reported seven cases of milk alkali syndrome who were seen between 1990-93 accounting for 12% of cases presenting to their hospital with severe hypercalcaemia. 4 It can cause life threatening complications and indeed both our patient and the one described by Brandwein and Sigman 2 needed admission to an intensive care unit. It is a diagnosis that is not easily made unless a careful patient history is takenwhich should include details of all self medication. Although the liver is considered to be a hormone independent organ, it is hormone responsive and endocrine alterations aVect hepatic function. We present a case of metabolic coma due to hyperammonaemia and myxoedema in a patient with well compensated cirrhosis and primary hypothyroidism. Coma developed after discontinuation of thyroid hormone replacement and it appears that hypothyroidism precipitated hyperammonaemia.
Case report
A previously healthy, functional 74 year old women was admitted in coma after being found unresponsive in her flat. Several days before she had fallen and struck her head without loss of consciousness. Since then, she had exhibited slurred speech and did not seem herself. Her past medical history as reported at the time of admission was remarkable for well compensated hepatitis C of approximately 20 years' duration. A search of the patient's flat found no prescription medication. She neither smoked nor drank. Examination revealed a thin female in coma with shallow, irregular respirations. Her pulse was 95 beats/min, blood pressure was 120/50 mm Hg, and respirations were 6-8/min. A healing contusion was noted on her forehead. Examination of the abdomen showed the liver to be of normal span with a firm edge. There was no splenomegaly or ascites noted. There was no oedema or spider angiomas, but palmar erythema was noted. Neurologically, she was unresponsive. Her Glasgow coma score was 3.
A complete blood count, electrolytes, urinalysis, and prothrombin time were within normal limits. Results of liver chemistry were (normal limits): aspartate aminotransferase (AST) 156 U/L (11-35), alanine aminotransferase (ALT) 53 U/l (7-46), alkaline phosphatase 113 U/l (46-139), total bilirubin 37. A diagnosis of hepatic coma was made and the patient started on lactulose. Within 24 hours, the ammonia level decreased to 52 µmol/l, but her mental status was unchanged. Because of the poor clinical response, other aetiologies for metabolic encephalopathy were sought. A morning cortisol was normal and a serum toxin screen was negative. Her serum thyroid stimulating hormone was 104 mU/l (0.47-6.90).
Intravenous levothyroxine 0.05 mg was administered intravenously every six hours. Over the next day, the patient gradually regained consciousness and her mental status returned to normal over the following days. Once alert, she informed the staV that she had a long history of hypothyroidism treated with levothyroxine. She had discontinued it two months before admission at the urging of her chiropodist who had instead recommended a herbal preparation to stimulate the thyroid. She was discharged to home shortly thereafter on levothyroxine and is euthyroid with no evidence of hepatic dysfunction.
Discussion
This unusual case demonstrates the complex interactions of liver and thyroid. It shows that hyperammonaemia may accompany profound hypothyroidism in patients with coexisting liver disease and that the presence of hyperammonaemia, particularly in the absence of other evidence of hepatic decompensation, should prompt a search for hypothyroidism.
Thyroid test abnormalities are common in both acute and chronic liver disease, but most patients remain euthyroid. The most common abnormalities are increases of total thyroxine and thyroxine binding globulin in association with normal free thyroxine and thyroid stimulating hormone concentrations. 1 2 Increased concentrations of total thyroxine appear due to increased thyroxine binding globulin, which have been variously attributed to release by damaged hepatocytes, decreased thyroxine binding globulin catabolism, or increased synthesis by regenerating hepatocytes.
3 Serum triiodothyronine concentrations in chronic liver disease are variable but generally decrease with increasing hepatic dysfunction. 4 Thyroid dysfunction may also occur in association with chronic liver disease most commonly in immune mediated liver disorders, particularly autoimmune chronic active hepatitis, primary biliary cirrhosis, and hepatitis C. 5 6 Hypothyroidism is more common than hyperthyroidism. Antithyroglobulin and antimicrosomal antibodies are often positive even in the absence of thyroid dysfunction. Thyroid antibodies are detected in 36%-72% of patients with autoimmune chronic active hepatitis and primary biliary cirrhosis and in 6%-14% of patients with chronic hepatitis C. 6 7 Conversely, both hyperthyroidism and hypothyroidism can adversely aVect hepatic structure and function. Hyperthyroidism is associated with increases in serum transaminases, alkaline phosphatase, and serum bilirubin concentrations. 8 Liver biopsy specimens in hyperthyroid patients most often show non specific changes including hepatocyte degeneration, cholestasis, and KupVer cell hyperplasia. 8 Although hyperthyroidism may alter hepatic histology and biochemistry, the clinical picture is usually dominated by the signs and symptoms of hyperthyroidism and diagnosis is not diYcult.
DiVerentiation of hypothyroidism from hepatic dysfunction can be diYcult, particularly in patients with coexisting liver disease as symptoms of hypothyroidism and chronic liver disease are similar. In both, patients may present with fatigue or mental status changes, as well as weakness, myalgias, and dyspnoea on exertion. Oedema, ascites, and pleural eVusion are seen in both disorders. Transaminase increases are common, often with AST raised out of proportion to ALT, as was seen here. While these increases may be caused by the steatosis which has been reported in hypothyroidism, AST increases may also be caused by myopathy.
While myxoedema may cause coma, it may not have been the sole cause of coma in this patient. Profound hyperammonaemia was noted at the time of admission without other evidence for hepatic dysfunction, such as coagulopathy, jaundice, or ascites. The eVect of thyroxine on ammonia metabolism is not well understood. Although protein synthesis is decreased in hypothyroidism, 9 urea production and the activities of urea cycle enzymes are increased in rats with experimental hypothyroidism. 10 11 These observations would suggest that hypothyroidism may increase ammonia production. There is only one other reported case of hypothyroidism, hyperammonaemia, and apparent portosystemic encephalopathy in a patient in a patient with cirrhosis. 12 In that report, a patient with altered mental status and decompensated liver disease, including hyperammonaemia, failed to respond to protein restriction and lactulose. Further investigation disclosed hypothalamic hypothyroidism and the patient's mental status was restored after administration of thyroxine. Interestingly, the electroencephalograms in both this and the previous reports disclosed generalised slowing and triphasic waves suggestive of hepatic encephalopathy. While this pattern is seen in a variety of metabolic encephalopathies, including hyperthyroidism, it is uncommon in hypothyroidism which more often demonstrates only diVuse slowing. 13 In summary, diVerentiating hypothyroidism from hepatic dysfunction may occasionally be diYcult, particularly in the setting of preexisting liver disease. Hyperammonaemia and mental status changes in chronic liver disease may be due to hypothyroidism. If suspected portosystemic encephalopathy does not respond to therapy, clinicians should evaluate for coexistent hypothyroidism.
Learning points x Thyroid and liver disease may coexist. Serum creatinine, urine analysis, arterial blood gas values, and thyroid hormones were normal. Her serum potassium concentration was 3.9 mmol/l. Urinary catecholamines and plasma cortisol were normal. Electrocardiography, chest radiography, and a duplex scan of the renal arteries were normal. Urine sodium excretion was reduced to 17 mmol/day. Urinary cortisol was 196 nmol/24 hour (high normal), urinary aldosterone was 1.3 nmol/24 hour (low), and plasma renin activity was 0.15 ng/l (very low) suggesting presence of an aldosterone-like substance.
Further inquiries revealed daily consumption of large amounts of "Turkish Pepper" (Karl Fazer Ltd, Helsinki, Finland, fig 1) , a brand of liquorice candies containing 200 mg glycyrrhicinic acid and 1.5 g of sodium/100 g. Moreover, to our astonishment, the patient was incidentally seen ingesting "Fisherman's Friend" (Lofthouse Ltd, Fleetwood, UK, fig 2) liquorice lozenges containing 200 mg glycyrrhicinic acid and 60 mg sodium chloride/100 g. and sodium chloride. Her urinary sodium excretion was markedly reduced suggesting that (provided that urine collection was adequate) she was not in equilibrium which would eventually have led to normal urinary sodium excretion. Therefore, although we cannot strictly prove a cause-and-eVect relationship, we assume that her hypertension was caused by recent large amounts of liquorice.
Women receiving oral contraceptives are predominantly aVected and a large proportion of patients is employed in oYce jobs. Individual susceptibility may play a part as many normotensive women report abuse of liquorice. An occasional patient may be a smoker who recently stopped only to "abuse" liquorice as a substitute. Near fatal cases have been reported 9 and severe neurological rhabdomyolysis may occur when profound hypokalaemia is present. 10 Hypertension in among the most frequently encountered problems in general internal medicine. Inquiring into liquorice habits must be part of the initial assessment to allow for a timely diagnosis of this common and easily treatable form of hypertension.
Mrs Pia Virtanen (Fazer Ltd, Helsinki, Finland), and Mr Dennis Walker (Lofthouse of Fleetwood, Fleetwood, UK) very kindly provided information regarding the ingredients of their respective products. In particular, we are indebted to Mrs Ilse Böger (Kadó liquorice store, Berlin) who introduced us to the art and science of liquorice confectionery. This paper is dedicated to Professor K Sack, Consultant Emeritus, Department of Medicine/Nephrology, University of Lübeck Medical School, Lübeck, Germany.
